EMA Application withdrawn: OraNera — CellSeed Europe Ltd

View source ↗

Summary

Application withdrawn for OraNera by CellSeed Europe Ltd in the corneal diseases area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Diseases

Drugs mentioned

• OraNera (autologous oral mucosal epithelial cells)

Snippet

Status: Application withdrawn. Therapeutic area: Corneal Diseases. MAH: CellSeed Europe Ltd. Decision date: 22/03/2013